Drug Manufacturers - Major Equities Technical Updates -- TherapeuticsMD, Sanofi, Shire, and Novartis

NEW YORK, NY / ACCESSWIRE / February 04, 2016 / Park Lane Advisor has initiated coverage on the following equities: TherapeuticsMD Inc. (NYSE MKT: TXMD), Sanofi (NYSE: SNY), Shire PLC (NASDAQ: SHPG), and Novartis AG (NYSE: NVS). Free research report on TherapeuticsMD can be accessed at http://www.parklaneadvisor.com/ On Wednesday, February 03, 2016, the NASDAQ Composite ended at 4,504.24, down 0.28%, the Dow Jones Industrial Average advanced 1.13%, to finish the day at 16,336.66, and the S&P 500 closed at 1,912.53, up 0.50%. The gains were broad based as six out of nine sectors ended the session in positive. Register for your complimentary reports at the links given below.

TherapeuticsMD Inc.'s stock lost 1.02% lower, to close the day at $6.80. The stock recorded a trading volume of 2.13 million shares, below its three months average volume of 2.53 million shares. TherapeuticsMD Inc.'s shares have surged 6.08% in the previous three months and 61.14% in the past one year, but the stock has declined 30.68% in the last one month. The company's shares are trading 6.59% below their 200-day moving average. Additionally, TherapeuticsMD Inc. has a Relative Strength Index (RSI) of 38.13. Sign up and read the free notes on TXMD at:

http://www.parklaneadvisor.com/

On Wednesday, shares in Sanofi recorded a trading volume of 1.93 million shares, higher than their three months average volume of 1.83 million shares. The stock ended the day 0.51% higher at $41.03. Shares of the company traded at a PE ratio of 19.00. The company is trading below its 50-day and 200-day moving averages by 2.88% and 14.66%, respectively. Furthermore, shares of Sanofi have an RSI of 47.46. The complimentary notes on SNY can be downloaded in PDF format at:

http://www.parklaneadvisor.com/

Shire PLC's stock finished Wednesday's session 2.92% lower at $162.81. A total of 2.63 million shares were traded, which was above its three months average volume of 1.34 million shares. The company's shares are trading below their 50-day and 200-day moving averages by 15.81% and 27.63%, respectively. Shire PLC's stock traded at a PE ratio of 10.54 and has an RSI of 30.45. Register for free on Park Lane Advisor and access the latest research on SHPG at:

http://www.parklaneadvisor.com/

On Wednesday, shares in Novartis AG ended the session 0.90% higher at $76.51. The stock reported a trading volume of 2.21 million shares, above its three months average volume of 2.11 million shares. Shares of the company traded at a PE ratio of 22.24. The company is trading 8.79% below its 50-day moving average and 19.30% below its 200-day moving average. Moreover, shares of Novartis AG have an RSI of 36.33. The complete research on NVS is available for free at:

http://www.parklaneadvisor.com/

--

About Park Lane Advisor:

Park Lane Advisor ("PLA") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. PLA has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PLA has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.

NO WARRANTY

PLA, the Author, the Reviewer and the Sponsor (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PLA nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit www.ParkLaneAdvisor.com

RESTRICTIONS

PLA is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: media (at) ParkLaneAdvisor (dot) com

SOURCE: Park Lane Advisor

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.